CVB — Curvebeam AI Cashflow Statement
0.000.00%
HealthcareMicro Cap
- AU$74.68m
- AU$74.25m
- AU$8.06m
Annual cashflow statement for Curvebeam AI, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PRESS |
Standards: | IFRS | IFRS | — |
Status: | Final | Final | Final |
Changes in Working Capital | 0 | 0.011 | 0.113 |
Other Operating Cash Flow | |||
Cash from Operating Activities | -1.51 | -7.99 | -21.7 |
Capital Expenditures | -0.295 | -0.257 | -0.842 |
Purchase of Fixed Assets | |||
Purchase / Acquisition of Intangibles | |||
Other Investing Cash Flow Items | 0 | 0 | -3.26 |
Sale of Business | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | -0.295 | -0.257 | -4.1 |
Financing Cash Flow Items | — | — | -0.136 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 1.7 | 16.5 | 22.3 |
Foreign Exchange Effects | |||
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | -0.111 | 8.5 | -3.54 |